Genetic substrates of cue-reactivity and cocaine motivation
- Institution
- STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY
- Principal investigator
- Paul J Meyer
- Funding
- $791K
- Duration
- 2025–2030
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Understanding the genetic factors that contribute to the transition from recreational to problematic drug use is vital for uncovering biological mechanisms that can aid in preventing and treating substance use disorders (SUDs). Genome wide association studies (GWAS) have been successful in identifying genetic variants, but validating these genes is diĜcult given that human research is limited to non-invasive approaches. Other approaches include integrating GWAS results with large-scale ‘omics’ datasets, and conducting functional studies in animal models. One such model is the intermittent-access cocaine self-administration procedure (IntA), which triggers increased cocaine motivation (i.e., incentive sensitization) in rats after only limited amounts of drug exposure. This models the transition into early stages of SUD and, when compared to other procedures, can be used to dissociate total drug intake from incentive sensitization. To uncover the genetic factors behind incentive sensitization during IntA, our team has conducted a GWAS in a limited sample of heterogeneous stock rats and identiffied genomic regions that inĚuence cocaine motivation and contain several candidate genes. Increasing the power of this study in Aim 1 will enable the discovery of additional gene variants contributing to the complex genetic landscape of SUD. Yet, candidate genes must be investigated with follow-up studies. In a separate project, multi-level ‘omics’ data (including GWAS results, phenome-wide association studies, and transcriptomics) were integrated to identify candidate gene variants underlying cue-reactivity, a trait that that is phenotypically and genetically correlated with measures of cocaine-cue reactivity. These candidates included the understudied genes Tenm4 and Far1. Subsequent behavioral neuroscience-based approaches established that administration of a Tenm4-associated peptide reduced several measures of cocaine motivation during IntA and thus conffirmed Tenm4's pleiotropic eěect on cocaine motivation and cue-reactivity. However, further characterization of Tenm4 and Far1 is needed, thus another goal of this project is to use CRISPR-based transcriptional manipulation to determine the roles of these genes in cocaine cue-reactivity and motivation (Aim 2). Finally, another approach for validating GWAS ffindings involves generating polygenic scores (PGSs) that can be used to predict cue-reactivity in naïve rats. In Aim 3, these PGSs will be used to determine the interaction between genetic vulnerability to cue-reactivity and changes in drug motivation during multiple cocaine self-administration paradigms. Thus, this project will enhance the understanding of genetic factors inĚuencing SUD susceptibility, validate candidate genes, and determine how genetic predisposition interacts with drug exposure to produce addiction- like behaviors. These goals align directly with those of those of the NIDA Animal Genomics Program, that is, “to identify [genetic variants] that underlie … phenotypes associated with addictive behaviors … behaviors associated with SUD, [and] uncover the function of known or newly discovered genetic or epigenetic variants”.
LOADING MOONBASE SCORE
Questions for STATE UNIVERSITY OF NEW YORK AT BUFFALO
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · State University of New York at BuffaloNot yet scored
Set and setting: the effects of psilocybin on nicotine self-administration in rats
Paul J Meyer · $81K · 2024–2026
- NIH · State University of New York at Buffalo48
Bacterial sialometabolic activity impacts periodontal immunity and microbiota
Ashu Sharma · $379K · 2020–2026
- NIH · State University of New York at Buffalo46
Model-aided Design and Integration of Functionalized Hybrid Nanomaterials for Enhanced Bioremediation of Per-and Polyfluoroalkyl Substances (PFASs)
Diana S Aga · $282K · 2021–2025